PLAU and cancer: In this respect, a large body of evidence shows that the urokinase-type plasminogen activator and its receptor (uPA/uPAR system) play key roles in mediating proteolysis during cancer invasion and metastasis and correlate with both tumor invasiveness and poor prognosis [4].